Mediwound Ltd (MDWD)

[midastouch017]

MediWound Announces Exercise of Over-Allotment Option

https://finance.yahoo.com/news/mediwound-announces-exercise-over-allotment-200500442.html

YAVNE, Israel, March 22, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (“MediWound”), a biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration, today announced that the underwriter of its recently completed public offering of ordinary shares, which closed on March 7, 2022, partially exercised their over-allotment option, having purchased an additional 623,082 ordinary shares. The closing of the partial exercise of the option occurred on March 22, 2022.

The gross proceeds of approximately $1.2 million from the partial exercise of the option brings the total amount raised in MediWound’s public offering to $11.2 million. MediWound intends to use the net proceeds from the offering for working capital and other general corporate purposes.

Oppenheimer & Co. Inc. acted as the sole book-running manager for the offering.